[1]
“CLINICAL UTILITY OF CIRCULATING TUMOR DNA (ctDNA) AS A PROGNOSTIC MARKER IN NON-SMALL CELL LUNG CANCER: A PROSPECTIVE COHORT STUDY”, FMHR, vol. 3, no. 6, pp. 1724–1731, Aug. 2025, Accessed: Oct. 27, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1166